News | Procedure Navigation Systems | February 05, 2019

Medtronic Recalls Synergy Cranial Software and Stealth Station S7 Cranial Software

Class I recall initiated due to inaccuracies displayed during surgical procedures

Medtronic Recalls Synergy Cranial Software and Stealth Station S7 Cranial Software

February 5, 2019 — Medtronic is recalling the Synergy Cranial Software and StealthStation S7 Cranial Software used with the StealthStation Surgical Navigation System due to reports of incorrect information displaying during biopsy procedures. The company said this could result in serious or life-threatening patient harm.

The Synergy Cranial Software and StealthStation S7 Cranial Software, used with the StealthStation Surgical Navigation System, provides detailed three-dimensional (3-D) images of a patient's brain to help neurosurgeons safely navigate surgical tools and implants used during brain surgery.

During a biopsy procedure, Medtronic said the software monitor may show that the tip of the surgical tool has not yet reached the planned target and may prevent the neurosurgeon from being able to accurately see the location of surgical tools in the patient's brain. In the event this software defect occurs, the neurosurgeon could potentially insert the surgical tool too deeply and damage the patient's healthy tissue, brain or blood vessels.

On Sept. 21, 2018, Medtronic sent an Urgent Medical Device Correction notice to customers. The notice provided the following mitigation to eliminate the risk of damaging healthy tissue:

  • Do not set a projection longer than the length of the surgical plan;
  • Follow the Cranial Software Pocket Guide, and always use the Biopsy Needle Mechanical Depth Stop; and
  • Ensure the Navigate Instrument Tip setting is selected prior to locking the trajectory and navigating the instrument.

The notice also instructed customers to take the following actions:

  • Review the notice and ensure appropriate staff are aware of the issue;
  • Sign and date the Consignee Response Form attached to the notice, and return the form to Medtronic by email at [email protected] or fax to Medtronic Technical Services at 651-367-7075 within 30 days of receipt.

On Dec. 28, Medtronic reported they were continuing to follow up with customers about  their Urgent Medical Device Correction over the next months.

Affected model numbers include:

  • 9733763 with software versions 2.2.0, 2.2.5, 2.2.6, 2.2.7
  • 9735585 with software versions 3.0.0, 3.0.1, 3.0.2, 3.1.0

All affected devices were manufactured from Aug. 31, 2011, to Oct. 16, 2018, and were distributed between the same dates.

Customers who have questions or need additional information or support related to this recall should contact Medtronic Technical Services at 1-888-826-5603. Healthcare professionals and consumers may report adverse reactions or quality problems they experience using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by fax to 1-800-FDA-0178.

For more information: www.medtronic.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Book Chapter Reports on Fonar Upright MRI for Hydrocephalus Imaging

Rotary misalignment of atlas (C1) and axis (C2). Image courtesy of Scott Rosa, DC, BCAO.

News | Magnetic Resonance Imaging (MRI) | March 20, 2019
Fonar Corp. reported publication of a chapter where the physician-author-researchers utilized the Fonar Upright Multi-...
Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research
News | Stroke | March 19, 2019
iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
New MRI Sensor Can Image Activity Deep Within the Brain
News | Magnetic Resonance Imaging (MRI) | March 15, 2019
Calcium is a critical signaling molecule for most cells, and it is especially important in neurons. Imaging calcium in...
Iron Measurements With MRI Reveal Stroke's Impact on Brain

Images show illustrative examples of visual R2? modifications within substantia nigra (SN) at baseline (24-72 h) and follow-up (1 y) in striatum (participants 1 and 2) and control groups (participants 3 and 4). Image courtesy of the Radiological Society of North America (RSNA).

News | Stroke | March 12, 2019
March 12, 2019 — A simple ...
iSchemaView Launches RAPID Angio
Technology | Angiography | March 01, 2019
iSchemaView announced the release of RAPID Angio, a complete neuroimaging solution for the angiography suite that...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with...
Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019
Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its augmented reality (AR) technology...
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a...